|Mr. D. Keith Grossman||Chairman, CEO & Pres||1.4M||N/A||1960|
|Mr. Roderick H. MacLeod||Chief Financial Officer||546.9k||N/A||1967|
|Mr. Kashif Rashid||Gen. Counsel, Corp. Sec. & Chief Compliance Officer||605.57k||N/A||1974|
|Mr. Andrew H. Galligan||Exec. Officer||776.95k||11.81M||1956|
|Ms. Niamh Louise Pellegrini||Chief Commercial Officer||701.21k||328.45k||1967|
|Mr. Patrick Schmitz||VP of Operations||N/A||N/A||1960|
|Ms. Julie D. Dewey||VP of Investor Relations & Corp. Communications||N/A||N/A||1961|
|Mr. Michael Collier Carter||VP of Global Sales||N/A||N/A||1972|
|Mr. Jon R. Shear||VP of Corp. Devel.||N/A||N/A||N/A|
|Ms. Lori M. Ciano||Chief HR Officer||N/A||N/A||1963|
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. In addition, the company provides HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
Nevro Corp.’s ISS Governance QualityScore as of June 1, 2021 is 5. The pillar scores are Audit: 4; Board: 5; Shareholder Rights: 5; Compensation: 5.